Benzinga | Dec 8, 2020 09:06AM EST

Cemtrex Announces 'Ongoing Engagements' With HBO Max And Modelo

Brooklyn, NY, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Cemtrex Inc. (NASDAQ:CETX, CETXP, CETXW))))), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality (AR/VR), today announced ongoing engagements with HBO Max, a pay television network, and Modelo USA, brewer of Modelo beer, to create AR/VR technology experiences in two digital marketing campaigns.



For HBO Max, Cemtrex built a dynamic digital marketing campaign for HBO Max's first exclusive movie, Charm City Kings. Cemtrex Labs, a Cemtrex Company, delivered eye-catching social media assets, a portal for a writing contest, along with an AR face filter and name generator to drive social engagement. The campaign combines the best of traditional digital marketing campaigns with exciting AR technology to reach a wider audience, boost social engagement and build awareness for the movie.

For Modelo, Cemtrex Labs built a powerful augmented reality web experience to promote the company's Modelo x RSVP WebAR Sweepstakes. RSVP Gallery, a conceptual retail experience, and Modelo USA partnered to create a co-branded apparel collection that pays homage to the fighting spirit of Chicago's iconic sports culture. The experience allows users to engage with the apparel in AR before entering the sweepstakes.

"The challenge to reach target audiences and engage them in a fun, sustained and creative way is driving interest in our services, and we are excited to be working with some of the most well-known names in the industry," commented Cemtrex's CEO, Saagar Govil. "Adding AR/VR experiences to mobile and digital campaigns is proving effective to increase participation, improve consumer interaction and drive results. We believe our AR/VR segment will continue to win additional contracts with partners and global brands who are seeking the best technologies combined with our proven development process."